Zydus Lifesciences last week said it has received final approval from the United States Food and Drug Administration (USFDA) to market its generic version of triazolam tablets used on a short-term basis to treat insomnia.
Edits by EP News Bureau
Zydus Lifesciences last week said it has received final approval from the United States Food and Drug Administration (USFDA) to market its generic version of triazolam tablets used on a short-term basis to treat insomnia.
Edits by EP News Bureau
Good post but I was wondering if you could write a litte more on this subject? I’d be very thankful if you could elaborate a little bit further. Appreciate it!
thanks for sharing all info!